The Renal Association seeks to involve its Corporate Members widely in all areas of the Association’s activities of mutual relevance. Contact the Secretary or the Treasurer to discuss this.
Otsuka Pharmaceutical is a global healthcare company, founded in 1921 in Naruto, Japan.Our vision is to continue to be innovative, creative and determined to deliver products that will have a positive impact on the lives of people throughout the world.
Our emphasis on unconventional thinking has resulted in the discovery and development of products to treat mental health disorders; kidney, cardiovascular, gastrointestinal and infectious diseases; and blood-related cancers. The Otsuka philosophy remains ‘Otsuka people creating new products for better health worldwide’.
Otsuka Pharmaceutical has research programmes for several, under-funded, diseases which affect global public health, including tuberculosis. Since 2014 we have launched a new anti-tuberculosis drug, the first for over 40 years as well as the first-ever drug treatment for polycystic kidney disease.
The Otsuka Group of companies employs approximately 47,000 people globally with a presence in over 170 countries.